ArticleInternational journal of immunopathology and pharmacology
Coexistence of anti-topoisomerase I and anticentromere antibodies in a patient with systemic sclerosis. Efficacy of treatment combining rituximab and nintedanib. A case report.
Lydia Montolio-Chiva et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.